Navigation Links
Additional Clinical Trial to be Conducted for KYNAPID Under FDA Special Protocol Agreement
Date:8/10/2009

he replay.

About KYNAPID

KYNAPID (vernakalant hydrochloride) Injection, or vernakalant (iv), is an investigational new drug for the rapid conversion of acute atrial fibrillation to sinus rhythm. Its mechanism of action involves the selective blockade of multiple ion channels in the heart that are known to be active during episodes of atrial fibrillation.

In October 2003, Cardiome granted Astellas Pharma US, Inc. an exclusive license to develop and commercialize KYNAPID in North America, with Astellas responsible for 75% of development costs. Astellas and Cardiome conducted four successful Phase 3 clinical trials which demonstrated the potential for KYNAPID as a conversion agent. In December 2004 and September 2005, we announced positive top-line results for the first and second pivotal Phase 3 atrial fibrillation trials, or ACT 1 and ACT 3, respectively. In addition, positive top-line results from ACT 2, evaluating KYNAPID for the treatment of atrial fibrillation following cardiac surgery, were announced in June 2007. Astellas also conducted an open-label safety study, or ACT 4, in order to gather additional safety data.

The NDA for KYNAPID was submitted in December 2006. In December 2007, the FDA Cardiovascular and Renal Drugs Advisory Committee recommended to the FDA that KYNAPID be approved for rapid conversion of acute atrial fibrillation to sinus rhythm. In August 2008, Astellas received an Approvable letter from the FDA.

About Cardiome

Cardiome Pharma Corp. is a product-focused drug development company dedicated to the advancement and commercialization of novel treatments for disorders of the heart and circulatory system. Cardiome is traded on the NASDAQ National Market (CRME) and the Toronto Stock Exchange (COM). For more information, please visit our web site at www.cardiome.com.

About Astellas


'/>"/>
SOURCE Cardiome Pharma Corp.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine news :

1. aTyr Pharma Raises an Additional $12 Million
2. Texas Kidney Community: CMS Authorization to Survey 22 New Dialysis Centers Excellent First Step Toward Opening Additional Pending Facilities, Creating More Local Jobs
3. SETO Holdings, Inc. Enters Into Two Additional Leases for Two New Hearing Centers in Maryland and Virginia
4. Mylan Receives FDA Approval for Additional Strengths of the Antipsychotic Haloperidol
5. For Treatment of Type 2 Diabetes, 89 Percent of Surveyed Endocrinologists Identify a Need for Additional GLP-1 Analogues and 71 Percent Say the Same About DPP-IV Inhibitors
6. Specialty Hospitals of Washington Adds Additional Skilled Nursing Facility Beds at United Medical Center in South East DC
7. King Provides Additional Information on the REMOXY(R) NDA Resubmission Plan
8. Visit to the doctor: The supply of additional private services is increasing
9. Business, Health Care Leaders Call on Texas Employers to Cover Smoking Cessation Benefits for an Additional 100,000 People by 2010
10. Mylan Receives FDA Approval for Additional Strength of Generic Restoril(R)
11. New Jersey University Hospital to Pay Additional $2 Million to Resolve Fraud Claims That Facility Double Billed Medicaid
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/3/2015)... ... 03, 2015 , ... Hunters Creek Retrievers is again honored to ... Black Lab Puppy. Celebrate Fall 2015 with unlimited Free Hugs and K9 Kisses from ... Thanksgiving and Christmas with an extra big smile. , This adorable trained Lab ...
(Date:9/3/2015)... ... September 03, 2015 , ... “We wish ... can impact the delicate life balance between work and leisure to the benefit ... R. Leaptrott, CEO , A LifeMinder Plus® Emergency Care Document Set duly executed ...
(Date:9/3/2015)... (PRWEB) , ... September 03, 2015 , ... “Love in ... , Google Play , and Amazon and will be released on ... from “My Darling is a Foreigner,” Itsuka, an actress and singer/songwriter, and Jason London, ...
(Date:9/3/2015)... CA (PRWEB) , ... September 03, 2015 , ... ... received a top review from Clinicians Report of Provo, Utah. The Clinicians Report ... by a selected group of dentists located throughout the U.S. Whiter Image's In-Office ...
(Date:9/3/2015)... ... 03, 2015 , ... About 220,800 new cases of prostate cancer are reported each year, along ... with prostate cancer during their lifetime. While only one man in 10,000 will typically get ... age 65, according to the American Cancer Society. , Prostate cancer ...
Breaking Medicine News(10 mins):Health News:Hunters Creek Retrievers Is Honored to Support the Lone Survivor Foundation with a Championship Trained Black Labrador Retriever Puppy 2Health News:Hunters Creek Retrievers Is Honored to Support the Lone Survivor Foundation with a Championship Trained Black Labrador Retriever Puppy 3Health News:LifeMinder Plus® Announces Emergency Care Document Set Giveaway for America 2Health News:LifeMinder Plus® Announces Emergency Care Document Set Giveaway for America 3Health News:The Romantic Comedy Film "Love in Tokyo" Has Been Released on ITunes, Google Play, and Amazon 2Health News:Whiter Image Products Get Positive Rating From The Clinicians Report 2Health News:Noted Santa Rosa Urologist Dr. Michael Lazar Provides Insights on Prostate Cancer Treatments in Recognition of Prostate Cancer Awareness Month 2Health News:Noted Santa Rosa Urologist Dr. Michael Lazar Provides Insights on Prostate Cancer Treatments in Recognition of Prostate Cancer Awareness Month 3
... ... This new cosmetic procure allows for breast augmentation without general anesthesia. The patient is ... ... relatively new technique for augmenting breasts called Awake Breast Aug. Jane Z., a patient of ...
... ... The Army has selected DOMA Technologies to provide Medical ... provide Business-To-Business remote coding services using their iCodeRx SaaS application and ... team will code, abstract, analyze and assemble medical record data and ...
... differently , SATURDAY, April 10 (HealthDay News) -- ... a different way, introverted or shy people respond differently ... to a new study. , About 20 percent of ... be seen in children who are reserved, need little ...
... ... Infection, Acute and Chronic Sinusitis for 25,000 patients with nebulized sinus medication therapy since ... ... is very proud to announce that it has reached an important milestone in its ...
... ... ... Still University’s Arizona School of Health Sciences (ATSU-ASHS) held its spring commencement ceremony ... 312 students earned a master of science or doctoral degree in Human Movement, Physician Assistant ...
... MONTREAL, QUEBEC Researchers from the Children,s Cancer Hospital at ... have found a way to more accurately predict treatment outcomes ... simple complete blood count test, also known as a CBC. ... at the American Society of Pediatric Hematology Oncology,s (ASPHO) annual ...
Cached Medicine News:Health News:Dr. Robert True Responds to a New York Time Article About a New Cosmetic Procedure Called Awake Breast Augmentation 2Health News:Army Awards Remote Medical Coding Contract to DOMA Technologies 2Health News:Shyness May Be Rooted in Brain Processing 2Health News:Sinus Dynamics Reaches Milestone with Treatment of Nasal Allergy, Sinus Infection, Acute and Chronic Sinusitis Treating 25,000th Patient 2Health News:ATSU –ASHS Holds Spring Commencement Ceremony 2Health News:M. D. Anderson zeroes in on better way to predict prognosis in pediatric leukemia patients 2
(Date:9/3/2015)... Calif. and REHOVOT, Israel, Sept. 3, 2015 ... on acquiring and developing innovative therapies for ear, nose, ... the Irvine Company,s Newport Gateway office complex to be ... to complete the move by end of September and ... U.S. Headquarters: OticPharma, Inc. 19900 ...
(Date:9/2/2015)... YORK , Sept. 2, 2015  The report ... future market of breast cancer drugs on the basis ... cancer usually originates from the inner lining of milk ... is a malignant type of tumor that can spread ... of cancer which starts in lobules is referred as ...
(Date:9/2/2015)... -- Advanced Wound Dressings - 5EU Analysis and ... steadily replaced traditional bandages and gauze materials in ... such as trauma wounds, burns, and chronic ulcerations. ... become increasingly critical in wound healing, advanced dressings ... This report focuses on nine market categories within ...
Breaking Medicine Technology:OticPharma Establishes U.S. Headquarters in Orange County, California 2Breast Cancer Therapeutics: Pipeline Analysis Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023 2Breast Cancer Therapeutics: Pipeline Analysis Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023 3Advanced Wound Dressings - 5EU Analysis and Market Forecasts 2
Utrata-like fine angled tips with gently curved shaft for performing capsulorhexis through tunnel incisions. Dull finish. Round handle manufactured in titanium....
Delicate 45 degrees angled shafts and Arruga style tips provide a firm purchase on the lens capsule. Round handle with dull finish....
This cross action forcep has delicate tips for grasping the capsule. The forcep has an iris stop to prevent inadvertent grasping of the iris....
Fine angled 12 mm shafts and iris stop. Round handle for fingertip rotational control. Dull finish....
Medicine Products: